Skip to main content
OpenTrials
Completed

NCT Number: NCT05134272

Infant Modified Constraint Induced Movement Therapy Paired With Neuromuscular Electrical Stimulation: a Case Series

This study will compare the motor outcomes for five infants with asymmetrical hand function (AHF) who will receive two, three week episodes of standard care separated by a three week episode of mCIMT paired with Neuromuscular Electrical Stimulation. The results of this study will inform decisions on the feasibility and efficacy of the treatment for use in a larger study for infants with AHF at risk for unilateral cerebral palsy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

7 month–10 month

Sex eligibility

All sexes

Study type

Observational

Primary location

Children's Minnesota

Maple Grove, Minnesota, 55369, United States

About this study

Infants with asymmetrical hand function will participate in three consecutive phases of treatment.

The first and third phase will consist of three weeks of standard care for children with asymmetrical hand function, 1 hour/day, 1 day/week. The therapist will provide weekly coaching with the parents so they can carry over activities at home one hour/day, six days/week during this phase. In addition, a sock or mitten will be used for short term constraint during the hour of training both in the clinic with the therapist and at home with the parent.

The second phase will consist of three weeks of modified constraint induced movement therapy, 2 hours/day, 3 days/week paired with NMES, 15 minutes/day, 3 days/week. The infants will wear a soft splint on their preferred hand and forearm 24 hours/day during this phase. Parents will be trained by the therapist to carry over activities with their child at home, 1 hour/day, 6 days/week.

The children will return at chronological age of 18 months for follow up testing.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Infant is 7-10 months of age (CCA)
  • Clinical presentation of asymmetrical hand function,
  • Grade 2/5 movement in more impaired upper extremity,
  • Demonstrate potential to participate in 6 hours of therapy/week during 3 week episode of mCIMT-NMES, as determined by principal investigator,
  • Parent/guardian willing to be partners in study and participate in follow-up assessments until child is 18 months of age

Exclusion criteria

  • Medical or sensory condition that prevents full therapy participation (active seizures, significant visual impairment)
  • Received Botox injection to more impaired upper extremity within last 6 months,
  • NMES contraindicated (impaired skin integrity, presence of pacemaker, clotting disorder),
  • Previous UE surgery or nerve injury (brachial plexus)

Treatment and study plan

Neuromuscular Electrical Stimulation

Device

Neuromuscular Electrical Stimulation will be applied by the therapist to infant's finger flexors and extensor for 15 min./day, 3x/week.

Other names: NMES

Modified Constraint Induced Movement Therapy

Behavioral

Modified CIMT will consist of constraint 24 hours/day using a splint in addition to therapy two hours/day, 3x/week for three weeks. Parents will be trained to carry over home program activities one hour/day, 6 days/week.

Other names: mCIMT

Standard care for infant with asymmetrical hand function

Behavioral

Infants will receive one hour of therapy, one time/week for three weeks. Parents will be trained to carry over home program activities one hour/day, 6 days/week. In addition the infant will wear a sock on their preferred hand during the hour of therapy/home program activity.

Primary outcomes

  1. Change in hand use based on the Hand Assessment of Infants

    Time frame: Baseline, week 4, week 7, week 10

    A criterion, norm referenced assessment that evaluates and measures goal directed both hand use and possible upper limb asymmetry in infants at risk of developing cerebral palsy,aged 3-12 months.

Secondary outcomes

  1. Change in motor skills based on the Peabody Developmental Motor Scales-2

    Time frame: Baseline, week 4, week 7, week 10, 18 months CCA

    A criterion and norm referenced test that measures fine and gross motor skill

  2. Assisting Hand Assessment Version 4.4

    Time frame: 18 months CCA

    A criterion-referenced test that measures and describes how effectively children who have unilateral disability, aged 18 months to 12 years, use their affected hand in bimanual activity performance.

Sponsors and collaborators

Lead sponsor

Kathy Grinde

Other

Registry information

Important dates

Study start
2021
Primary completion
2022
Study completion
2023
First posted
Nov 24, 2021
Registry last updated
Jun 27, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.